![HAT Medium Supplement 50X, Liquid w/ 680.5 mg per litre Hypoxanthine, 8.8 mg/litre Aminopterin and 193.8 mg/litre Thymidine in Phosphate Buffered Saline 10ml HAT supplement is sufficient for 500ml medium [TCL072]](/web/image/product.product/48778/image_1024/%5BTCL072-100ML%5D%20HAT%20Medium%20Supplement%2050X%2C%20Liquid%20w-%20680.5%20mg%20per%20litre%20Hypoxanthine%2C%208.8%20mg-litre%20Aminopterin%20and%20193.8%20mg-litre%20Thymidine%20in%20Phosphate%20Buffered%20Saline%2010ml%20HAT%20supplement%20is%20sufficient%20for%20500ml%20medium%20%5BTCL072%5D%20%28100ML%29?unique=04030b9)
HAT Medium Supplement 50X, Liquid w/ 680.5 mg per litre Hypoxanthine, 8.8 mg/litre Aminopterin and 193.8 mg/litre Thymidine in Phosphate Buffered Saline 10ml HAT supplement is sufficient for 500ml medium [TCL072]
[TCL072] HAT supplement contains Hypoxanthine, Aminopterin and Thymidine and is used for the preparation of selection medium for hybridoma. The myeloma cell is deficient in enzyme hypoxanthine-guanine phosphoribosyl transferase (HGPRT) or thymidine kinase (TK), and cannot survive in selection medium containing hypoxanthine, aminopterin and thymidine. TCL072 is a sterile filtered 50X HAT medium supplement containing 680.5 mg/litre Hypoxanthine, 8.8 mg/litre Aminopterin and 193.8 mg/litre Thymidine in Phosphate Buffered Saline.
Net weight: TCL072-100ML: 0,1 kg
TCL072-10X10ML: 0,1 kg
TCL072-5X10ML: 0,05 kg
xxx DRY ICE (-20 C°) xxx
[TCL072] HAT supplement contains Hypoxanthine, Aminopterin and Thymidine and is used for the preparation of selection medium for hybridoma. The myeloma cell is deficient in enzyme hypoxanthine-guanine phosphoribosyl transferase (HGPRT) or thymidine kinase (TK), and cannot survive in selection medium containing hypoxanthine, aminopterin and thymidine. TCL072 is a sterile filtered 50X HAT medium supplement containing 680.5 mg/litre Hypoxanthine, 8.8 mg/litre Aminopterin and 193.8 mg/litre Thymidine in Phosphate Buffered Saline.
Specifications
| Units | 100ML or 10x10ML or 5x10ML |